Accessibility Menu

Best Genetic Sequencing Stocks to Buy in 2026 and How to Invest in Them

By Keith SpeightsUpdated Feb 5, 2026 at 12:02 PM EST | Fact-checked by Frank Bass

Key Points

  • Global genetic sequencing market projected to reach $92 billion by 2033.
  • Falling sequencing costs enable new market opportunities, enhancing growth potential.
  • Illumina leads with 80% market share, advances in clinical and research applications.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.